FDA Adverse Event
Death
Summary report: N
AGENT
MDR report key: 19538837
·
Received June 14, 2024
Report
- Report Number
- 2124215-2024-35956
- Event Type
- Death
- Date Received
- June 14, 2024
- Date of Event
- February 2, 2024
- Report Date
- June 14, 2024
- Manufacturer
- BOSTON SCIENTIFIC CORPORATION
- Product Code
- OOB
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- JA
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
Description of Event or Problem · 0
JAPAN ALLIANCE REGISTRY. IT WAS REPORTED THAT A PATIENT DEATH OCCURRED. ON (B)(6) 2023, AN AGENT DCB MR 3.50 X 20MM WAS SELECTED FOR TREATMENT OF THE 75% STENOSED TARGET LESION. THE PATIENT WAS DISCHARGED WITH NO COMPLICATIONS ON (B)(6) 2023. HOWEVER, ON (B)(6) 2024, THE PATIENT DIED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 373743 | AGENT | DRUG-ELUTING PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY CATHETER | OOB | BOSTON SCIENTIFIC CORPORATION | 3825 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 85 YR | Male | Death |